Injecting Equipment Sharing among Injecting Drug Users in Togliatti City, Russian Federation: Maximizing the Protective Effects of Syringe Distribution

Journal of Acquired Immune Deficiency Syndromes

Volumn 35, Issue 3, 2004, Pages 293-300

  Rhodes, Tim ^a,g   Judd, Ali ^a   Mikhailova, Larissa ^b,c   Sarang, Anya ^d   Khutorskoy, Mikhail ^e   Platt, Lucy ^a   Lowndes, Catherine M ^f   Renton, Adrian ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b City Narcological Services   (Russian Federation)

^c NGO Parents Against Drugs ^*  (Russian Federation)

^d AIDS Foundation East West   (Russian Federation)

^e Togliatti City Administration   (Russian Federation)

^f CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

HIV prevention; Injecting drug use; Injecting risk behavior; Russia; Syringe exchange

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; DRUG ABUSE PATTERN; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INJECTION DRUG ABUSE; INTRAVENOUS DRUG ABUSE; LAW ENFORCEMENT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEEDLE; PRIORITY JOURNAL; RISK FACTOR; RUSSIAN FEDERATION; SYRINGE;

ANALYSIS OF VARIANCE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 1442324030     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200403010-00011     Document Type: Article

References (42)

1. Rhodes T, Ball A, Stimson GV, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe. Addiction. 1999;94:1323-1336.
2. Federal AIDS Centre. HIV Infection: Informational Bulletin (September 2003). Moscow, 2003.
3. Susser M, Susser E. Choosing a future for epidemiology: from black box to Chinese boxes and eco-epidemiology. Am J Public Health. 1996;86: 674-678.
4. Rhodes T, Stimson GV, Crofts N, et al. Drug injecting, rapid HIV spread and the 'risk environment.' AIDS 1999;13(Suppl A):S259-S269.
5. Diez-Roux AV. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. Am J Public Health. 1998;88:216-222.
6. Bourgois P. Anthropology and epidemiology of drugs: the challenges of cross-methodological and theoretical dialogue. Int J Drug Policy. 2002; 13:259-269.
7. Barnett T, Whiteside A, Khodakevich L, et al. The HIV epidemic in the Ukraine: its potential social and economic impact. Soc Sci Med. 2001;51: 1387-1403.
8. Grund JPC, Kobzev D, Melnikov V, et al. Drug use patterns and HIV risk behaviors of Russian syringe exchange participants. Presented at the 12th International Conference on the Reduction of Drug-Related Harm, New Delhi, 2001.
9. Rhodes T, Sarang A, Bobrik A, et al. HIV transmission and HIV prevention among injecting drug users in Russia. Int J Drug Policy. 2004;15: 1-16.
10. Des Jarlais DC, Friedmann P. Grund JPC. et al. HIV risk behaviour among participants of syringe exchange programmes in central/eastern Europe and Russia. Int J Drug Policy. 2002;13:165-170.
11. Power R, Nozhkina N. Correspondence: the value of process evaluation in sustaining HIV harm reduction in the Russian Federation. AIDS. 2002;16: 303-304.
12. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS. 1993;7:1653-1660.
13. Stark K, Muller R, Bienzle U, et al. Frontloading: a risk factor for HIV and hepatitis C virus infection among injection drug users in Berlin. AIDS. 1996;10:311-317.
14. Abdala N, Stephens PC, Griffith BP, et al. Survival of human immunodeficiency virus type I in syringes. J Acquir Immune Defic Syndr. 1999; 20:73-80.
15. Des Jarlais DC, Perlis T, Freidman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health. 2000;90:1112-1116.
16. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329-1341.
17. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797-1800.
18. Bastos FI, Strathdee S. Evaluating the effectiveness of syringe exchange programmes. Soc Sci Med. 2000;51:1771-1782.
19. USAID and Centers for Disease Control. HIV/AIDS Strategy in Russia, 1998-2000, Washington: USAID; 1998.
20. Burrows D. A Best Practice Model of Harm Reduction in the Community and in Prisons in the Russian Federation, Washington: World Bank; 2001.
21. Koester S. Copping, running and paraphernalia laws: contextual variables and needle risk behaviour among injecting drug users in Denver. Hum Organ. 1994;53:287-295.
22. Blumenthal R, Kral A, Lorvivk J, et al. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1997;18:61-84.
23. Case P, Meehan T, Jones S. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S71-S75.
24. Maher L, Dixon D. Policing and public health: law enforcement and harm minimisation in a street-level drug market. Br J Criminol. 1999;39:488-511.
25. Aitken C, Moore D, Higgs P, et al. The impact of a police crackdown on a street drug scene: evidence from the street. Int J Drug Policy. 2002;13: 189-198.
26. Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange practices in Togliatti City, Russian Federation. Soc Sci Med. 2003;57:39-54.
27. Poloubinskaya SV. Russian Legislation and the Prevention of HIV Among Intravenous Drug Users. Moscow: Open Society Institute; 1999.
28. Rhodes T, Lowndes CM, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russian Federation. AIDS. 2002;16(Suppl):F25-F32.
29. Grund JPC, Kaplan CD, Adriaans NFP, et al. Drug sharing and HIV transmission risks: the practice of 'frontloading' in the Dutch drug injecting drug user population. J Psychoactive Drugs. 1991;23:1-10.
30. Connell JA, Parry JV, Mortimer PP, et al. Novel assay for the detection of immunoglobulin G anti-human immunodeficiency virus in untreated saliva and urine. J Med Virol. 1993;41:159-164.
31. Connell JA, Parry JV. Detection of anti-HIV in saliva and urine at the time of seroconversion. Clin Diagn Virol. 1994;1:299-311.
32. Tamashiro N, Constantine N. Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ. 1994;72:135-143.
33. Paoli L. The development of an illegal market: drug consumption and trade in post-Soviet Russia. Br J Criminol. 2002;42:21-39.
34. Mokienko M, Mokienko I. Harm reduction programme in Sakhalin, Russia. Presented at the 12th International Conference on the Reduction of Drug Related Harm, New Delhi, 2001.
35. Tsekhanovich A, Dughin S. Harm reduction programs and police: confrontation or mutual understanding? Presented at the 12th International Conference on the Reduction of Drug Related Harm, New Delhi, 2001.
36. Drucker E, Lurie P, Wodak A, et al. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998;12(Suppl A):S217-S230.
37. Taussig JA, Weinstein B, Burris S, ct al. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS. 2000;14(Suppl 1):S47-S51.
38. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of IDUs and police officers - Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:82-89.
39. Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS. 2000;14(Suppl 1):S41-S46.
40. Bray S, Lawson R, Heimer R. Doffing the cap: increasing syringe availability by law but not in practice. Int J Drug Policy. 2001;12:221-235.
41. Weinstein B, Toce P, Katz D, et al. Peer education of pharmacists and supplying pharmacists with IDU packets to increase injection drug users' access to sterile syringes in Connecticut [letter]. J Acquir Immune Defic Syndr Human Retrovirol. 1998;18(Suppl 1):S146-S147.
42. Abdala N, Gleghorn AA, Carney JM, et al. Can syringes be safely cleaned? Implications for transmission among injection drug users. J Acquir Immune Defic Syndr. 2001;28:487-494.